Rua Bioscience Limited — Share Issue/Capital Change 2022

Feb 4, 2022

Template

==> picture [101 x 49] intentionally omitted <==

Capital Change Notice

Updated as at 17 October 2019

Section 1: Issuer information	Section 1: Issuer information
Name of issuer		Rua Bioscience Limited
NZX ticker code		RUA
Class of financial product		Equity Security (ordinaryshares)
ISIN (If unknown, check on NZX website)		NZRUAE0004S1
Currency		NZD
Section 2: Capital change details
Number issued	/acquired/redeemed	8,140,000
Nominal value	(if any)	N/A
Issue/acquisition/redemption price per security		N/A
Nature of the payment (for example, cash or otherconsideration)		Other consideration
Amount paid up (if not in full)		Paid up in full
Percentage of total class of Financial Productsissued/acquired/redeemed/(calculated on the number ofFinancial Products of the Class, excluding any Treasury Stock,in existence)1		5.74%
For an issue of Convertible Financial Products or Options, theprincipal terms of Conversion (for example the Conversionprice and Conversion date and the ranking of the FinancialProduct in relation to other Classes of Financial Product) or theOption (for example, the exercise price and exercise date)		N/A
Reason for issue/acquisition/redemption and specific authorityfor issue/acquisition/redemption/ (the reason for change mustbe identified here)		Acquisition of ZalmTherapeutics Limited
Total number of Financial Products of the Class after theissue/acquisition/redemption/Conversion (excluding TreasuryStock) and the total number of Financial Products of the Classheld as Treasury Stock after the issue/acquisition/redemption.		149,879,267
In the case of an acquisition of shares, whether those sharesare to be held as treasury stock		N/A
Specific authority for the issue, acquisition, or redemption,including a reference to the rule pursuant to which the issue,acquisition, or redemption is made		Shareholder Resolution dated19 January 2022 andDirectors' resolution andDirectors'' certificate dated onour about the date of issueListing Rules 4.6.1 and5.2.2(e)

1 The percentage is to be calculated immediately before the issue, acquisition, redemption or Conversion.

Terms or details of the issue, acquisition, or redemption (forexample: restrictions, escrow arrangements)	N/A
Date of issue/acquisition/redemption2	04/02/2022
Section 3: Authority for this announcement and contact person
Name of person authorised to make this announcement	Hamish White
Contact person for this announcement	Kerry Donovan
Contact phone number
Contact email address	Kerry.donovan@ruabio.com
Date of release through MAP	02/02/2022

2 Continuous issuers using this form in reliance on Rule 3.13.2, please indicate the period during which the relevant issue/acquisition/redemptions were made (for example, 1 January 2019 to 31 January 2019).